Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide
- 1 May 2000
- journal article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 25 (10), 1087-1092
- https://doi.org/10.1038/sj.bmt.1702384
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 16 references indexed in Scilit:
- Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effectBone Marrow Transplantation, 1999
- Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasiaMedical and Pediatric Oncology, 1999
- Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failureBone Marrow Transplantation, 1998
- Patterns of gonadal dysfunction following bone marrow transplantationBone Marrow Transplantation, 1998
- Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trialBritish Journal of Haematology, 1998
- Ovarian function after bone marrow transplantation during childhoodBone Marrow Transplantation, 1998
- Growth in Children Undergoing Bone Marrow Transplantation After Busulfan and Cyclophosphamide ConditioningJournal of Pediatric Hematology/Oncology, 1996
- Acute myeloid leukaemia in patients with trisomy 21 (Down syndrome) treated by bone marrow transplantationJournal of Paediatrics and Child Health, 1994
- Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiationBlood, 1992
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976